Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.

Blood pharmacokinetics and tissue distribution of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a boron carrier with postulated melanin-seeking properties for boron neutron capture therapy, were determined in C57/BL mice with subcutaneous pigmented or non-pigmented B16 melanomas. Borocaptate sodium...

Descripción completa

Detalles Bibliográficos
Autores principales: Verrijk, R., Smolders, I. J., Huiskamp, R., Gavin, P. R., Philipp, K. H., Begg, A. C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968811/
https://www.ncbi.nlm.nih.gov/pubmed/8142252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968811/
https://www.ncbi.nlm.nih.gov/pubmed/8142252

Ejemplares similares